Celerion

Andrew Baxter, Ph.D., MBA, possesses over 15 years of commercial experience in the life sciences industry, currently serving as Senior Director of Business Development for Global Early Clinical Development Solutions at Celerion. They have previously held leadership roles at organizations such as BioAgilytix, Charles River Laboratories, and GlaxoSmithKline, focusing on business development and scientific innovation in drug development. Andrew earned a Ph.D. in Neuroscience from the University of Edinburgh and an MBA in Strategic Management from Aston Business School. Known for their consultative approach, Andrew is dedicated to fostering impactful collaborations within the industry.

Org chart

Teams

Clinical Development

Offices